ArticleQatar medical journal2026
Massive uterine angiomyolipoma mimicking uterine leiomyoma in a 49-year-old woman.
Article in Qatar medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Angiomyolipoma (AML) is a rare benign mesenchymal tumor, originating from perivascular epithelioid cells (PECs), composed of smooth muscle, fat, and thick-walled blood vessels, most often found in the kidney. Uterine AML is exceptionally rare, with under 40 cases reported worldwide and 3 from India prior to the present case. Unlike renal AMLs, uterine lesions are typically sporadic and not linked to tuberous sclerosis (TS), which, combined with their resemblance to fibroids, makes preoperative diagnosis challenging. Case Description: A 49-year-old woman presented with six months of progressive lower abdominal distension and three months of amenorrhea. She had no signs of TS. Physical examination revealed a firm, non-mobile pelvic mass extending to the xiphisternum. Contrast-enhanced Computed Tomography (CT) showed a 27 × 18 × 19 cm submucosal uterine mass with right hydroureteronephrosis; Cancer Antigen-125 (CA 125 ag) was normal. A total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed, revealing a 7 kg anterior wall tumor. Histopathology confirmed classic AML architecture-interlacing smooth muscle bundles, mature adipocytes, and hyalinized blood vessels-without atypia or mitotic activity. She recovered well. Discussion: Uterine AML is a "diagnostic chameleon," often mistaken for leiomyomas, lipoleiomyomas, or degenerated fibroids on imaging. Definitive diagnosis relies on histopathological examination. Each reported case contributes vital insights into this rare gynecologic entity and highlights the need to include AML in the differential diagnosis of unusual uterine masses. Conclusion: This case underscores the importance of maintaining clinical suspicion for uterine AML when encountering large or atypical uterine lesions. Our patient underwent a hysterectomy and had an uneventful recovery. Histologic confirmation and complete surgical excision are key to optimal management and favorable outcomes, enriching our understanding of extrarenal AMLs in gynecologic practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.